Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Melanoma 1Lung Neoplasms 1Leiomyosarcoma 1Gastrointestinal Stromal Tumors 1Esophageal Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1Adenocarcinoma Of Esophagus 1

Interventions

Imatinib Mesylate 8Specimen Handling 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Ipilimumab 2CTLA-4 Antigen 2temsirolimus 1rubitecan 1romidepsin 1oblimersen 1motexafin lutetium 1guadecitabine 1alvocidib 1Sorafenib 1Sirolimus 1Semaxinib 1Rogaratinib 1Nivolumab 1Leucovorin 1Irinotecan 1Immunoglobulin G 1HhAntag691 1Floxuridine 1Erlotinib Hydrochloride 1Doxorubicin 1Disulfides 1Dasatinib 1Cetuximab 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Gastrointestinal Stromal Tumors × rubitecan × Clear all
NCT00005874 2013-12-04

Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
GastrointestinalSarcoma

Leiomyosarcoma, Sarcoma, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡